CPhI Worldwide – organized by UBM (part of Informa PLC) – has announced the opening of the 2018 CPhI Pharma Awards for entries. The industry’s preeminent awards return for a landmark 15th edition, with 17 categories honouring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies. This year's categories include: â Excellence in Pharma: CEO of the Year â Excellence in Pharma: Supply Chain, Logistics, and Distribution â Excellence in Pharma: Contract Services and Outsourcing â Excellence in Pharma: Regulatory Procedures and Compliance â Excellence in Pharma: Corporate Social Responsibility â Excellence in Pharma: Pharma Company of the Year â Excellence in Pharma: OTC â Excellence in Pharma: Patient Centricity â Excellence in Pharma: IT, mHealth & Digitalisation Last year, the awards received a record number of submissions (over 200 applications). CPhI Worldwide is expecting greater interest in 2018. Former winners of the CEO of the year award include Vivek Sharma, CEO of Piramal (winner in 2015); Udit Batra, CEO of Merck (winner in 2016), and last year Richard Chin, MD, founder and CEO of Kindred Biosciences. Another increasingly significant category is the Corporate Social Responsibility award, which will be given in partnership with official charity partner, International Medical Corps. Orhan Caglayan, Brand Director – CPhI Worldwide, UBM (part of Informa PLC), commented: “The awards are now rightly lauded as the most prestigious in pharma. If you or your company want to be recognized amongst the industry and your peers as driving forward developments, we encourage you to take part – all pharma and supply chain companies are welcome.” Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31, 2018 – with shortlisted finalists announced August 28, 2018. The winners will be unveiled during a ceremony at the prestigious Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide. To apply please visit https://awards.cphi.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.